CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION
Billions of doses.
Zero doubts.
WHAT WE DO
The nation’s leading CDMO specializing in Blow-Fill-Seal technology.
We deliver
We support
We commit to
WHAT WE DO
We deliver every time.
Blow-Fill-Seal is considered the gold-standard choice for sterile unit dose delivery. In a fully automated process, low-density polyethylene (LDPE) polymer is blown into a mold, filled with product, and sealed, sterile and ready for delivery and dosage. Ritedose integrates its best-in-class quality systems through the entire process—from development through commercial scale-up manufacturing—enabling the safe delivery of drugs to patients.
WHO WE SERVE
Our customers include early-stage drug developers and large pharmaceutical companies.
Perfecting the development and delivery of medications is a personal commitment for us. We honor patients and their caregivers, who depend on the high-quality medications we produce every day.
Driven by passion and precision, we are dedicated to our mission of transforming patients’ lives.
Perfected for patients.
WHY RITEDOSE?
Excellence and precision, always.
Ritedose is considered a leader in sterile BFS technology, providing safe, efficient and aseptic unit dose manufacturing. Since 2012, we’ve delivered billions of doses without a single patient interruption and exemplary compliance record. Our dedicated employees have friends and family who rely on our medications, and we take this personally, with zero margin for error.
70%
customer retention
5+
years’ experience
<6
days from formulation to shipment
1.5B+
units annually
Let’s
start
working
together
today.
Get in touch.
CDMO FAQs
A contract development and manufacturing organization (CDMO) is a “one-stop shop”, taking on nearly every step in the process of drug development, from managing clinical trials, FDA New Drug Application (NDA) approvals, to scaling up capacity, manufacturing and delivery.
Short for “Blow-Fill-Seal,” BFS is a safe and efficient method for producing drugs in aseptic conditions. Using this method, a manufacturer “blows” the liquid container materials into a mold, and lets it cool and assume its shape. Then, the container is “filled” with the drug, and “sealed” by closing the container opening. All of this is done with automated systems, in aseptic conditions.
Ritedose produces ampoules made of low-density polyethylene (LDPE) designed for sterile liquid medications. Current fill volumes supported are .2 to 15 mL, designed for inhalation, eye drop, otic, and oral liquids, but molds can be customized to meet customers’ needs.
Fill volumes range from 0.2 mL to 15 mL.
Ritedose’s equipment suite includes state-of-the-art BFS filling lines (Rommelag), and multiple robotic packaging systems (Syntegon & Sigpack).
We are the largest CDMO in the United States, specializing in sterile Blow-Fill-Seal (BFS) production of unit dose solutions for the ophthalmic and respiratory markets. Today, Ritedose has a production capacity of over 2.6B units annually in its 500,000-square-foot facility. It has produced more than 12 billion doses since 2012—without any patient interruptions.